| Judy Jia, MD | |
|
10905 Memorial Hermann Dr Ste 111, Pearland, TX 77584-3490 | |
| (281) 929-4727 | |
| (281) 929-4728 |
| Full Name | Judy Jia |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 14 Years |
| Location | 10905 Memorial Hermann Dr Ste 111, Pearland, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588983134 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hermann - Texas Medical Center | Houston, TX | Hospital |
| Midland Memorial Hospital | Midland, TX | Hospital |
| Memorial Hermann Hospital System | Houston, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mhs Physicians Of Texas | 1557254968 | 71 |
| Premier Family Care I, Inc | 2567351372 | 60 |
News Archive
Cardium Therapeutics reported today that its Cardium Biologics division provided an update on plans for the continuing commercial development of Generx™ (alferminogene tadenovec, Ad5FGF-4), a DNA-based angiogenic therapy product candidate for patients with coronary artery disease.
A new blood test identifies the sickest heart failure patients better than tests now used in emergency departments, researchers reported at the American Heart Association's Scientific Sessions 2008. Results of the Mid-Regional pro-Adrenomedullin (proADM) versus BNP and NTproBNP as Prognosticator in Heart Failure Patients: Results of the BACH Multinational Trial were presented as a late-breaking clinical trial.
New York Stem Cell Foundation (NYSCF)-Druckenmiller Fellow, Daylon James, PhD, of Weill Cornell Medial College, is lead author on a study defining conditions for generating a plentiful supply of endothelial (vessel lining) cells that are suitable for therapeutic use. Dr. James and his colleagues created a human embryonic stem cell (hESC) "reporter" line that can be used to measure endothelial cell production and activity.
In its newest report, Academic Health Centers and Community Health Centers: The Landscape of Current Partnerships, the Association of Academic Health Centers illustrates the significant management, education, and service collaborations between academic health centers and community health centers as they work together to sustain and expand health care access and delivery for communities across the country.
› Verified 3 days ago
| Entity Name | Scott & White Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093779704 PECOS PAC ID: 8123923604 Enrollment ID: O20031223000640 |
News Archive
Cardium Therapeutics reported today that its Cardium Biologics division provided an update on plans for the continuing commercial development of Generx™ (alferminogene tadenovec, Ad5FGF-4), a DNA-based angiogenic therapy product candidate for patients with coronary artery disease.
A new blood test identifies the sickest heart failure patients better than tests now used in emergency departments, researchers reported at the American Heart Association's Scientific Sessions 2008. Results of the Mid-Regional pro-Adrenomedullin (proADM) versus BNP and NTproBNP as Prognosticator in Heart Failure Patients: Results of the BACH Multinational Trial were presented as a late-breaking clinical trial.
New York Stem Cell Foundation (NYSCF)-Druckenmiller Fellow, Daylon James, PhD, of Weill Cornell Medial College, is lead author on a study defining conditions for generating a plentiful supply of endothelial (vessel lining) cells that are suitable for therapeutic use. Dr. James and his colleagues created a human embryonic stem cell (hESC) "reporter" line that can be used to measure endothelial cell production and activity.
In its newest report, Academic Health Centers and Community Health Centers: The Landscape of Current Partnerships, the Association of Academic Health Centers illustrates the significant management, education, and service collaborations between academic health centers and community health centers as they work together to sustain and expand health care access and delivery for communities across the country.
› Verified 3 days ago
| Entity Name | Mhs Physicians Of Texas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184714867 PECOS PAC ID: 1557254968 Enrollment ID: O20040207000177 |
News Archive
Cardium Therapeutics reported today that its Cardium Biologics division provided an update on plans for the continuing commercial development of Generx™ (alferminogene tadenovec, Ad5FGF-4), a DNA-based angiogenic therapy product candidate for patients with coronary artery disease.
A new blood test identifies the sickest heart failure patients better than tests now used in emergency departments, researchers reported at the American Heart Association's Scientific Sessions 2008. Results of the Mid-Regional pro-Adrenomedullin (proADM) versus BNP and NTproBNP as Prognosticator in Heart Failure Patients: Results of the BACH Multinational Trial were presented as a late-breaking clinical trial.
New York Stem Cell Foundation (NYSCF)-Druckenmiller Fellow, Daylon James, PhD, of Weill Cornell Medial College, is lead author on a study defining conditions for generating a plentiful supply of endothelial (vessel lining) cells that are suitable for therapeutic use. Dr. James and his colleagues created a human embryonic stem cell (hESC) "reporter" line that can be used to measure endothelial cell production and activity.
In its newest report, Academic Health Centers and Community Health Centers: The Landscape of Current Partnerships, the Association of Academic Health Centers illustrates the significant management, education, and service collaborations between academic health centers and community health centers as they work together to sustain and expand health care access and delivery for communities across the country.
› Verified 3 days ago
| Entity Name | Premier Family Care I, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275522864 PECOS PAC ID: 2567351372 Enrollment ID: O20040311000343 |
News Archive
Cardium Therapeutics reported today that its Cardium Biologics division provided an update on plans for the continuing commercial development of Generx™ (alferminogene tadenovec, Ad5FGF-4), a DNA-based angiogenic therapy product candidate for patients with coronary artery disease.
A new blood test identifies the sickest heart failure patients better than tests now used in emergency departments, researchers reported at the American Heart Association's Scientific Sessions 2008. Results of the Mid-Regional pro-Adrenomedullin (proADM) versus BNP and NTproBNP as Prognosticator in Heart Failure Patients: Results of the BACH Multinational Trial were presented as a late-breaking clinical trial.
New York Stem Cell Foundation (NYSCF)-Druckenmiller Fellow, Daylon James, PhD, of Weill Cornell Medial College, is lead author on a study defining conditions for generating a plentiful supply of endothelial (vessel lining) cells that are suitable for therapeutic use. Dr. James and his colleagues created a human embryonic stem cell (hESC) "reporter" line that can be used to measure endothelial cell production and activity.
In its newest report, Academic Health Centers and Community Health Centers: The Landscape of Current Partnerships, the Association of Academic Health Centers illustrates the significant management, education, and service collaborations between academic health centers and community health centers as they work together to sustain and expand health care access and delivery for communities across the country.
› Verified 3 days ago
| Entity Name | Round Table Specialist Group, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497152268 PECOS PAC ID: 1254754609 Enrollment ID: O20200702000716 |
News Archive
Cardium Therapeutics reported today that its Cardium Biologics division provided an update on plans for the continuing commercial development of Generx™ (alferminogene tadenovec, Ad5FGF-4), a DNA-based angiogenic therapy product candidate for patients with coronary artery disease.
A new blood test identifies the sickest heart failure patients better than tests now used in emergency departments, researchers reported at the American Heart Association's Scientific Sessions 2008. Results of the Mid-Regional pro-Adrenomedullin (proADM) versus BNP and NTproBNP as Prognosticator in Heart Failure Patients: Results of the BACH Multinational Trial were presented as a late-breaking clinical trial.
New York Stem Cell Foundation (NYSCF)-Druckenmiller Fellow, Daylon James, PhD, of Weill Cornell Medial College, is lead author on a study defining conditions for generating a plentiful supply of endothelial (vessel lining) cells that are suitable for therapeutic use. Dr. James and his colleagues created a human embryonic stem cell (hESC) "reporter" line that can be used to measure endothelial cell production and activity.
In its newest report, Academic Health Centers and Community Health Centers: The Landscape of Current Partnerships, the Association of Academic Health Centers illustrates the significant management, education, and service collaborations between academic health centers and community health centers as they work together to sustain and expand health care access and delivery for communities across the country.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Judy Jia, MD 10905 Memorial Hermann Dr Ste 111, Pearland, TX 77584-3490 Ph: (281) 929-4727 | Judy Jia, MD 10905 Memorial Hermann Dr Ste 111, Pearland, TX 77584-3490 Ph: (281) 929-4727 |
News Archive
Cardium Therapeutics reported today that its Cardium Biologics division provided an update on plans for the continuing commercial development of Generx™ (alferminogene tadenovec, Ad5FGF-4), a DNA-based angiogenic therapy product candidate for patients with coronary artery disease.
A new blood test identifies the sickest heart failure patients better than tests now used in emergency departments, researchers reported at the American Heart Association's Scientific Sessions 2008. Results of the Mid-Regional pro-Adrenomedullin (proADM) versus BNP and NTproBNP as Prognosticator in Heart Failure Patients: Results of the BACH Multinational Trial were presented as a late-breaking clinical trial.
New York Stem Cell Foundation (NYSCF)-Druckenmiller Fellow, Daylon James, PhD, of Weill Cornell Medial College, is lead author on a study defining conditions for generating a plentiful supply of endothelial (vessel lining) cells that are suitable for therapeutic use. Dr. James and his colleagues created a human embryonic stem cell (hESC) "reporter" line that can be used to measure endothelial cell production and activity.
In its newest report, Academic Health Centers and Community Health Centers: The Landscape of Current Partnerships, the Association of Academic Health Centers illustrates the significant management, education, and service collaborations between academic health centers and community health centers as they work together to sustain and expand health care access and delivery for communities across the country.
› Verified 3 days ago
Tiffany Cossey, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10905 Memorial Hermann Dr Ste 111, Pearland, TX 77584 Phone: 281-929-4727 Fax: 281-929-4728 | |
Dr. Rebecca Helena Maxwell, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3518 Brandemere Dr, Pearland, TX 77584 Phone: 713-598-6265 Fax: 281-485-9089 | |
Leah Quezada Kolar Onoja, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 7501 Fite Rd, Pearland, TX 77584 Phone: 281-997-5515 | |
Dr. Chiyyarath V Sathees, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2225 County Road 90, Suite 201 G, Pearland, TX 77584 Phone: 832-654-4390 Fax: 281-265-2751 | |
Lynette M Gogol, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2225 County Rd 90, Suite 107, Pearland, TX 77584 Phone: 281-485-2337 Fax: 281-485-2985 | |
Dr. Irina Digilova, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 6302 West Broadway Street, Suite 230, Pearland, TX 77581 Phone: 281-529-6242 Fax: 281-741-4104 | |
Dr. Kathleen H. Eberle, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10905 Memorial Hermann Dr, Ste 115, Pearland, TX 77584 Phone: 713-947-3100 Fax: 713-704-1796 |